Eric B. Fastiff
Partner, San Francisco Office
415 956-1000

“Justice is about giving access to the legal system, trying to right wrongs that victims have suffered, be they people, governments, or companies.”
Eric B. Fastiff
Eric B. Fastiff

Eric B. Fastiff has practiced commercial litigation for the past 25 years, working on numerous cases involving the drug, food, technology, finance, and natural resource industries. He also represents businesses in commercial disputes with their suppliers and competitors. His clients include governments, Native American tribes and their health providers, businesses, individuals, and consumer groups.

Eric currently represents numerous Native American tribes and health providers seeking to recover damages the tribes suffered as a result of the Opioids and Juul epidemics.

Eric served as co-lead counsel in the California Cipro litigation, representing California consumers and third party payors in a state court class action lawsuit charging Bayer, Barr Labs, and other generic prescription drug manufacturers with a conspiracy to restrain competition in the sale of Bayer’s blockbuster antibiotic drug Ciprofloxacin, sold as Cipro. The 17-year litigation ultimately resulted in settlements totaling $399 million, a result the trial court described as “extraordinary.” Eric and the LCHB team’s work on the Cipro case led to recognition by California Lawyer and the Daily Journal as 2016 California Lawyers of the Year and receipt of the American Antitrust Institute’s 2017 award for Outstanding Private Practice Antitrust Achievement.

Eric also represents The Charles Schwab Corporation in a suit against several major banks for allegedly manipulating the London Interbank Offered Rate (LIBOR), and successfully led the prosecution of a two week arbitration on behalf of a client that alleged both intellectual property and breach of contract claims. Eric’s notable successes include representing businesses that purchased TFT-LCD panels and products in litigation charging that the world’s leading TFT-LCD manufacturers conspired to fix prices. The litigation resulted in settlements totaling over $470 million.

Long form bio (click to open pdf).

  • Cornell Law School, Ithaca, New York
    J.D. – 1995
    Law Journal: Cornell International Law Journal, Editor-in-Chief
  • London School of Economics, London, England
    M.Sc. (Econ.) – 1991
  • Tufts University, Medford/Somerville, Massachusetts
    B.A. (Cum Laude) – 1990
    Honors: Magno Cum Honore in Thesi
  • California, 1996
  • District of Columbia, 1997
  • U.S. Court of Appeals, Federal Circuit, 2007
  • U.S. Court of Federal Claims
  • U.S. Court Of Appeals, 2nd Circuit, 2013
  • U.S. Court of Appeals, 3rd Circuit, 2008
  • U.S. Court Of Appeals, 6th Circuit, 2015
  • U.S. Court Of Appeals, 7th Circuit
  • U.S. Court of Appeals, 9th Circuit, 1996
  • U.S. District Court, Central District of California, 1997
  • U.S. District Court, Eastern District of California, 2004
  • U.S. District Court, Northern District of California, 1997
  • U.S. District Court, Southern District of California, 2004
  • U.S. District Court, of the District of Columbia, 1999
  • American Antitrust Institute, Advisory Board, 2012 – Present
  • Bar Association of San Francisco
  • Children’s Day School, Board of Trustees
  • Committee to Support the Antitrust Laws, President, 2017
  • District of Columbia Bar Association
  • Journal of Generic Medicines, Editorial Board, 2003 – Present
  • State Bar of California
  • U.S. Court of Federal Claims Bar Association
  • Speaker, “Opportunities in Plaintiff-Side Tribal Law: A Conversation with Lieff Cabraser,” Berkeley Law, February 2024
  • General Editor, California Class Actions Practice and Procedures, 2003 – 2009
  • Coordinating Editor and Co-Author, California section of the ABA State Class Action Survey, 2003 – 2008
  • “US Generic Drug Litigation Update,” Journal of Generic Medicines 212, 2004
  • The Proposed Hague Convention on the Recognition and Enforcement of Civil and Commercial Judgments: A Solution to Butch Reynolds’s Jurisdiction and Enforcement Problems,” 28 Cornell International Law Journal 469, 1995
  • Selected for inclusion by peers in The Best Lawyers in America in the field of “Litigation – Antitrust,” 2013 – 2024
  • “Lawdragon 500 Leading Lawyers in America,” Lawdragon, 2019-2024
  • “Lawdragon 500 Leading Plaintiff Financial Lawyers in America,” Lawdragon, 2019-2023
  • “Top 100 Super Lawyers of Northern California,” Super Lawyers, 2020-2023
  • “Super Lawyer for Northern California,” Super Lawyers, 2010 – 2023
  • “Lawyer of the Year for Antitrust Litigation,” Northern California, Best Lawyers, 2021
  • “Plaintiffs’ Law Trailblazer, National Law Journal, 2018
  • “Outstanding Private Practice Antitrust Achievement,” American Antitrust Institute, 2017
  • “California Lawyer Attorney of the Year (CLAY) Award,” California Lawyer, 2016
  • “Top Plaintiff Lawyers,” Daily Journal, 2016-2017
  • “Leader in the Field” for Antitrust – Plaintiffs (California); Antitrust – Plaintiffs (Nationwide), Chambers USA, 2017
  • “California Litigation Star,” Benchmark Litigation, 2013 – 2015
  • “Top 100 Lawyers in California,” Daily Journal, 2013
  • Legal 500 recommended lawyer, LegalEase, 2013
  • “Top Attorneys in Business Law,” Super Lawyers Corporate Counsel Edition, 2012
  • “Lawdragon Finalist,” Lawdragon, 2009